Aimee L. Luat, M.D.
Associate Professor
Aimee L. Luat, M.D. Read More »
- Areas of Research/Scholarship Focus: Epilepsy/Tuberous Sclerosis/Sturge-Weber Syndrome
- Board Certification(s): Child Neurology/Clinical Neurophysiology and Epilepsy
- Medical School: University of Santo Tomas
- Internship: Children's Hospital of Michigan
- Residency: Children's Hospital of Michigan
- Fellowship: Children's Hospital of Michigan
- Awards/Honors:
- Detroit Top Docs 2019, 2020, 2021
- Primary Practice Name: Children's Hospital of MI
- Primary Practice Address: 3901 Beaubien - 3rd Floor
- Primary Practice City: Detroit
- Primary Practice State: MI
- Primary Practice Zip Code: 48201
- Practice Phone Number: (313) 745-5906
- Practice Fax: (313) 745-0955
- Accepted Insurance: We accept most types of insurance. Please call to confirm that your carrier is on our list.
- About the Provider:
Dr. Aimee F. Luat is Division Chief of Pediatric Neurology at the Children’s Hospital of Michigan and a Professor of Pediatrics at Central Michigan University College of Medicine. She is a board-certified pediatric neurologist, clinical neurophysiologist, and epileptologist with extensive training in pediatric neurology and epilepsy. Dr. Luat is widely recognized for her expertise in the evaluation and management of pediatric epilepsy and complex neurological disorders, including tuberous sclerosis complex and Sturge-Weber syndrome. She has played a central leadership role in multidisciplinary clinical programs, including co-directing the Tuberous Sclerosis Clinic and the Epilepsy Surgery Program.
Dr. Luat is an accomplished clinician-scientist with a strong record of peer-reviewed publications, book chapters, and NIH-funded collaborative research focused on neuroimaging, epilepsy, and neurodevelopmental outcomes. She has been consistently recognized for excellence in clinical care and education, including multiple “Top Doctors” honors and institutional teaching awards. In addition to her research and clinical leadership, she is deeply committed to training the next generation of physicians and advancing patient-centered, multidisciplinary care for children with neurological disorders.
Selected Publications
- [1] Hopkins S, Weber A, MacDougall J, Evanski J, Marusak HA, Luat AF. Preliminary prospective study of pharmaceutical-grade cannabidiol for seizure frequency, anxiety, and comorbid symptoms in pediatric epilepsy: Associations with circulating endocannabinoids and lipid biomarkers. Journal of Child Neurology. 2026.
- [2] Juhász C. Luat, AF, Behen ME, Kumar A. Introduction of a Brain MRI Scoring System with Clinical Relevance for Sturge-Weber Syndrome. Acad Rad 2026.
- [3] Luat AF, Hetrick KA. Pharmaceutical-grade cannabidiol in pediatric epilepsy. In: Cannabis and the Developing Brain. Springer Nature; 2025:83–114.
- [4] Juhász C, Luat AF, Behen ME, Gjolaj N, Jeong JW, Chugani HT, Kumar A. Deep Venous Remodeling in Unilateral Sturge-Weber Syndrome: Robust Hemispheric Differences and Clinical Correlates. Pediatr Neurol 2023: 49-58.
- [5] Luat AF, Juhász C, Loeb JA, Chugani HT, Falchek SJ, Jain B, et al. Neurological complications of Sturge-Weber syndrome: Current status and unmet needs. Pediatric Neurology. 2019;98:31–38.
- [6] Luat AF, Behen ME, Chugani HT, Juhász C. Cognitive and motor outcomes in children with Sturge-Weber syndrome: Effect of age at seizure onset and side of brain involvement. Epilepsy & Behavior. 2018;80:202–207.
- [7] Luat AF, Asano E, Kumar A, Chugani HT, Sood S. Corpus callosotomy for intractable epilepsy revisited: The Children’s Hospital of Michigan series. Journal of Child Neurology. 2017;32(7):624–629.









